High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients

High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients

•Higher SARS-CoV-2 seroprevalence in HIV patients in comparison to the general population in France.•High SARS-CoV-2 seroprevalence in African sub-Saharan HIV patients.•Active smoking is associated with a lower rate of SARS-CoV-2 antibodies.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infection 2022-08, Vol.85 (2), p.e33-e36
Hauptverfasser: ABDI, Basma, NDOADOUMGUE, Aude Laetitia, DJEBARA, Siham, ZAFILAZA, Karen, PALICH, Romain, MAROT, Stéphane, SCHNEIDER, Luminata, WIRDEN, Marc, SEANG, Sophie, DUDOIT, Yasmine, TEYSSOU, Elisa, TUBIANA, Roland, SOULIE, Cathia, VALANTIN, Marc Antoine, KATLAMA, Christine, CALVEZ, Vincent, ASSOUMOU, Lambert, MARCELIN, Anne-Geneviève, POURCHER, Valérie
Format: Artikel
Sprache:eng
Schlagworte:
COVID-19
HIV
Humoral immune response
Letter to the Editor
Risk factors
SARS-CoV-2
Seroprevalence
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Higher SARS-CoV-2 seroprevalence in HIV patients in comparison to the general population in France.•High SARS-CoV-2 seroprevalence in African sub-Saharan HIV patients.•Active smoking is associated with a lower rate of SARS-CoV-2 antibodies.
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2022.05.036